SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Tesla, Inc. – ‘10-Q’ for 9/30/14 – ‘EX-10.4’

On:  Friday, 11/7/14, at 5:08pm ET   ·   For:  9/30/14   ·   Accession #:  1193125-14-403635   ·   File #:  1-34756

Previous ‘10-Q’:  ‘10-Q’ on 8/8/14 for 6/30/14   ·   Next:  ‘10-Q’ on 5/11/15 for 3/31/15   ·   Latest:  ‘10-Q’ on 4/24/24 for 3/31/24   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/07/14  Tesla, Inc.                       10-Q        9/30/14   63:4.7M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    531K 
 2: EX-10.1     Material Contract                                   HTML     28K 
 3: EX-10.2     Material Contract                                   HTML    208K 
 4: EX-10.3     Material Contract                                   HTML     49K 
 5: EX-10.4     Material Contract                                   HTML     37K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
43: R1          Document and Entity Information                     HTML     43K 
33: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    125K 
41: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     43K 
                (Parenthetical)                                                  
45: R4          Condensed Consolidated Statements of Operations     HTML     78K 
                (Unaudited)                                                      
58: R5          Condensed Consolidated Statements of Cash Flows     HTML    142K 
                (Unaudited)                                                      
35: R6          Overview of the Company                             HTML     26K 
40: R7          Summary of Significant Accounting Policies          HTML     69K 
30: R8          Balance Sheet Components                            HTML     57K 
22: R9          Fair Value of Financial Instruments                 HTML     46K 
59: R10         Customer Deposits                                   HTML     23K 
47: R11         Convertible and Long-term Debt Obligations          HTML     42K 
46: R12         Equity Incentive Plans                              HTML     38K 
51: R13         Segment Information                                 HTML     29K 
52: R14         Strategic Partnerships                              HTML     28K 
50: R15         Commitments and Contingencies                       HTML     30K 
53: R16         Summary of Significant Accounting Policies          HTML     70K 
                (Policies)                                                       
42: R17         Summary of Significant Accounting Policies          HTML     61K 
                (Tables)                                                         
44: R18         Balance Sheet Components (Tables)                   HTML     61K 
49: R19         Fair Value of Financial Instruments (Tables)        HTML     50K 
63: R20         Equity Incentive Plans (Tables)                     HTML     31K 
55: R21         Overview of the Company - Additional Information    HTML     51K 
                (Detail)                                                         
37: R22         Summary of Significant Accounting Policies -        HTML     52K 
                Additional Information (Detail)                                  
48: R23         Summary of Significant Accounting Policies -        HTML     49K 
                Schedule of Account Activity Related to Resale                   
                Value Guarantee Program (Detail)                                 
39: R24         Summary of Significant Accounting Policies -        HTML     32K 
                Schedule of Accrued Warranty Activity (Detail)                   
19: R25         Summary of Significant Accounting Policies -        HTML     28K 
                Summary of Accounts Receivable from OEM Customers                
                in Excess of 10% of Total Accounts Receivable                    
                (Detail)                                                         
56: R26         Summary of Significant Accounting Policies -        HTML     31K 
                Schedule of Potential Weighted Common Shares                     
                Outstanding that were Excluded from Computation of               
                Basic and Diluted Net Loss per Share of Common                   
                Stock (Detail)                                                   
60: R27         Balance Sheet Components - Schedule of Inventory    HTML     34K 
                (Detail)                                                         
26: R28         Balance Sheet Components - Schedule of Property,    HTML     37K 
                Plant and Equipment, Net (Detail)                                
25: R29         Balance Sheet Components - Additional Information   HTML     40K 
                (Detail)                                                         
28: R30         Balance Sheet Components - Schedule of Other        HTML     30K 
                Assets (Detail)                                                  
29: R31         Balance Sheet Components - Schedule of Accrued      HTML     45K 
                Liabilities (Detail)                                             
31: R32         Balance Sheet Components - Schedule of Other        HTML     44K 
                Long-Term Liabilities (Detail)                                   
17: R33         Fair Value of Financial Instruments - Additional    HTML     30K 
                Information (Detail)                                             
54: R34         Fair Value of Financial Instruments - Schedule of   HTML     29K 
                Fair Value Hierarchy of Financial Assets Carried                 
                at Fair Value (Detail)                                           
36: R35         Fair Value of Financial Instruments -               HTML     31K 
                Available-for-Sale Marketable Securities (Detail)                
38: R36         Fair Value of Financial Instruments - Schedule of   HTML     25K 
                Changes in Fair Value of Common Stock Warrant                    
                Liability (Detail)                                               
21: R37         Customer Deposits - Additional Information          HTML     23K 
                (Detail)                                                         
62: R38         Convertible and Long-term Debt Obligations - 0.25%  HTML    123K 
                and 1.25% Convertible Senior Notes and Bond Hedge                
                and Warrant Transactions - Additional Information                
                (Detail)                                                         
15: R39         Convertible and Long-term Debt Obligations - 1.50%  HTML     93K 
                Convertible Senior Notes and Bond Hedge and                      
                Warrant Transactions - Additional Information                    
                (Detail)                                                         
32: R40         Convertible and Long-term Debt Obligations - Full   HTML     49K 
                Repayment of DOE Loan Facility and Expiration of                 
                DOE Warrant - Additional Information (Detail)                    
57: R41         Equity Incentive Plans - Additional Information     HTML     48K 
                (Detail)                                                         
20: R42         Equity Incentive Plans - Summary of Stock-Based     HTML     29K 
                Compensation Expense (Detail)                                    
24: R43         Segment Information - Additional Information        HTML     29K 
                (Detail)                                                         
27: R44         Strategic Partnerships - Additional Information     HTML     31K 
                (Detail)                                                         
34: R45         Commitments and Contingencies - Additional          HTML     45K 
                Information (Detail)                                             
61: XML         IDEA XML File -- Filing Summary                      XML     97K 
16: EXCEL       IDEA Workbook of Financial Reports                  XLSX    122K 
23: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    507K 
 9: EX-101.INS  XBRL Instance -- tsla-20140930                       XML    892K 
11: EX-101.CAL  XBRL Calculations -- tsla-20140930_cal               XML    190K 
12: EX-101.DEF  XBRL Definitions -- tsla-20140930_def                XML    417K 
13: EX-101.LAB  XBRL Labels -- tsla-20140930_lab                     XML   1.05M 
14: EX-101.PRE  XBRL Presentations -- tsla-20140930_pre              XML    695K 
10: EX-101.SCH  XBRL Schema -- tsla-20140930                         XSD    145K 
18: ZIP         XBRL Zipped Folder -- 0001193125-14-403635-xbrl      Zip    119K 


‘EX-10.4’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Prepared by R.R. Donnelley Financial -- EX-10.4  

Exhibit 10.4

 

LOGO   Confidential Treatment Requested by Tesla Motors, Inc.

 

October 1, 2014

 

To: Mr. JB Straubel
   Chief Technology Officer
   Tesla Motors, Inc.
   3500 Deer Creek Road
   Palo Alto, CA 94304

 

RE: Investment letter agreement for Panasonic’s [***] Production Line [***] at Giga-Factory

Dear JB-san,

This letter agreement (“[***] Investment Letter Agreement”) is entered into by and between Tesla Motors, Inc., a Delaware corporation (“Tesla”), and Panasonic Corporation, a Japanese corporation (“Panasonic”), effective as of the date last signed below with respect to Panasonic’s investment in the [***] Production Line [***] (defined below), as contemplated in the General Terms and Conditions dated October 1, 2014, including Section 1.1(b) thereof (the “General Terms”), and the Production Pricing Agreement dated October 1, 2014 (“Pricing Agreement”) by and between the Parties. Tesla and Panasonic are each referred to herein as a “Party” and collectively as the Parties.” This [***] Investment Letter Agreement is entered into in connection with, and subject to, the General Terms and the Pricing Agreement. Capitalized terms used in this [***] Investment Letter Agreement have the meanings given herein, in the General Terms and/or in the Pricing Agreement.

In consideration of the mutual premises and mutual covenants set forth below and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Tesla and Panasonic hereby agree as follows.

 

1.

Investment Commitment. Panasonic shall, at its cost and expense, supply all components (including but not limited to [***], but excluding [***] Tesla-Supplied Items), all engineering, manufacturing and other processes, all designs, and all research and development necessary to complete design, development, manufacture, assembly, installation of the Seller’s Property required for [***] for the manufacture of Goods which meet the requirements of the applicable Specifications (collectively, the “[***] Production Line [***]”) subject to (i) the Parties’ entering into the Factory Lease as contemplated in Section 11.1(a) of the General Terms by the Lease Target Date and (ii) that the General Terms remain effective at the time of such investment by Panasonic. The [***] Production Line [***] is described in more detail in Exhibit A hereto. Panasonic will make its investments in

 

 

[***] Production Letter Agreement   Page 1 of 6
[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.


LOGO

  Confidential Treatment Requested by Tesla Motors, Inc.

 

 

the [***] Production Line [***] over [***], with installation at the Factory beginning on an agreed date after [***]; provided, however, that the schedule for such installation is subject to timely completion of the Tesla Responsibilities described in Sections 2.4(a), 11.1(a) and 11.1(b) of the General Terms. It is currently anticipated by the Parties that the [***] Production Line [***] shall be capable of achieving a monthly production capacity of [***] Goods (i.e., approximately [***]). Panasonic shall take title to all equipment, tooling, components and similar tangible items included in the [***] Production Line [***] at the Factory.

 

2. Investment Cost. The total amount of the Seller Investment Cost required for the [***] Production Line [***] is referred to as the “[***] Production [***]”. Panasonic represents that its [***] of the [***] Production [***] as of the date of this [***] Investment Letter Agreement, including all costs to connect the [***] Production Line [***] to the Utilities at the Factory (the “Utility Infrastructure Costs”), is [***]. Panasonic will use its [***] of the [***] Production [***]. Panasonic will notify Tesla promptly in writing of any and all changes to the [***] Production [***]. If the [***] Production [***] exceeds the foregoing [***] by more than [***], but only to the extent such increase is not due to a reasonable increase in the Utility Infrastructure Costs, Tesla shall have no liability for such [***] unless Tesla has given prior written consent to be liable for such [***] (which Tesla shall not unreasonably withhold, condition or delay following a good faith discussion with Panasonic).

 

3. [***]. For purposes of and subject to Section 2(e) ([***] Seller Investment Cost) of the Pricing Agreement, (a) Seller will be deemed to [***] Production [***] through the sale of an agreed quantity of Goods, which will be reasonably agreed based on a good faith discussion by the Parties, over a period of [***] beginning on the [***] (as defined in the Pricing Agreement), and (b) Seller will be deemed to [***] of the [***] Production [***] through the sale of an agreed quantity of Goods, which will be reasonably agreed based on a good faith discussion by the Parties, over the [***] of the [***] period. Further, the [***] Production [***] shall [***], and Panasonic will be deemed to [***], by an amount equal to [***]. It is currently anticipated that [***] for the [***] Production Line [***] will begin on or around [***], and the actual [***] therefor will be separately agreed in writing between the Parties in accordance with Section 2(e)(i) of the Pricing Agreement.

 

4. Goods Pricing. The Unit Price of Goods shall be established in accordance with Pricing Agreement. The Parties agree that the supply of the Goods shall be pursuant to the General Terms.

 

5.

Target Purchase Quantity. The quarterly target quantity of Goods to be purchased by Tesla from Panasonic’s operating entity at the Factory (the “Target Purchase Quantity”) sets forth in Exhibit B, and the Parties will reference such quantities at the Production Meeting. If the first date that

 

 

[***] Production Letter Agreement   Page 2 of 6
[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.


LOGO   Confidential Treatment Requested by Tesla Motors, Inc.

 

 

Panasonic’s operating entity at the Factory delivers to Tesla Goods with use of the [***] Production Line [***] is delayed from the schedule set forth in Exhibit B for any reason, [***]. Tesla will use Commercially Reasonable Efforts to purchase Goods in accordance with the Target Purchase Quantities, subject to Section 1.6 of the General Terms and Section 3(b)(vii) of the Pricing Agreement.

 

6. Miscellaneous. To the extent applicable to the subject matter of this [***] Investment Letter Agreement, the General Terms and Pricing Agreement are each incorporated herein and form an integral part hereof. This [***] Investment Letter Agreement, together with such provisions of the General Terms and Pricing Agreement, constitutes the entire agreement between the Parties with respect to its subject matter and supersedes all prior agreements and understandings, both oral and written, between the Parties with respect thereto. If a conflict between the provisions of this [***] Investment Letter Agreement and those of the General Terms and/or Pricing Agreement, the conflict shall be resolved pursuant to Section 16.8 (Conflicts) of the General Terms. No subsequent terms, conditions, understandings, or agreements purporting to modify the terms of this [***] Investment Letter Agreement will be binding unless in writing and signed by both Parties. This [***] Investment Letter Agreement may be executed in counterparts, each of which when so executed and delivered will be deemed an original, and all of which taken together will constitute one and the same instrument. This [***] Investment Letter Agreement shall expire upon [***] in accordance with the Pricing Agreement and the terms hereof.

Sincerely yours,

/s/ Shinji Sakamoto

Shinji Sakamoto

Executive Officer

Senior Vice President

Automotive & Industrial Systems Company

Panasonic Corporation

 

 

[***] Production Letter Agreement   Page 3 of 6
[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.


LOGO   Confidential Treatment Requested by Tesla Motors, Inc.

 

 

Agreed to by Tesla Motors, Inc.

By: /s/ JB Straubel

Name: JB Straubel

Title: Chief Technology Officer, Tesla Motors, Inc.

 

 

[***] Production Letter Agreement   Page 4 of 6
[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.


LOGO   Confidential Treatment Requested by Tesla Motors, Inc.

 

 

Exhibit A – [***] Production Line [***]

[***]

 

 

[***] Production Letter Agreement   Page 5 of 6
[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.


  Confidential Treatment Requested by Tesla Motors, Inc.

 

Exhibit B – Target Purchase Quantity

Unit: Million Cells

[***]

 

 

[***] Production Letter Agreement   Page 6 of 6
[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/7/14
10/1/148-K
For Period end:9/30/14
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/29/24  Tesla, Inc.                       10-K       12/31/23  116:14M                                    Workiva Inc Wde… FA01/FA
 1/31/23  Tesla, Inc.                       10-K       12/31/22  125:30M                                    Donnelley … Solutions/FA
 5/02/22  Tesla, Inc.                       10-K/A     12/31/21   12:2.6M                                   ActiveDisclosure/FA
 2/07/22  Tesla, Inc.                       10-K       12/31/21  131:28M                                    Donnelley … Solutions/FA
 4/30/21  Tesla, Inc.                       10-K/A     12/31/20   12:2.3M                                   ActiveDisclosure/FA
 2/08/21  Tesla, Inc.                       10-K       12/31/20  149:31M                                    ActiveDisclosure/FA
Top
Filing Submission 0001193125-14-403635   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:14:45.1am ET